MIR9-2 and attention deficit-hyperactivity disorder: In humans, MIR9-2, or its transcript expression, was already associated with schizophrenia [26], attention deficit and hyperactivity disorder (ADHD) [27], and neuroticism [28], and a pleiotropic effect across disorders has been reported [29].